Peltz Stuart Walter's Form 4 filing
PTC Therapeutics, Inc. (PTCT) · filed Jan 12, 2023
- Accession no.
- 0001415889-23-000877
- Filed
- Jan 12, 2023
- Trade date
- Jan 10-11, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $151.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Peltz Stuart WalterCIK 0001578962 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 10, 2023 | Common Stock | SSaleDisposed | −1,228 | $42.93 | −$52,718.04 | 170,471 | Direct | |
| Jan 10, 2023 | Common Stock | SSaleDisposed | −571 | $42.93 | −$24,513.03 | 55,980 | Indirect | |
| Jan 11, 2023 | Common Stock | SSaleDisposed | −1,189 | $44.36 | −$52,744.04 | 169,282 | Direct | |
| Jan 11, 2023 | Common Stock | SSaleDisposed | −492 | $44.36 | −$21,825.12 | 55,488 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.